“Omics”-Informed Drug and Biomarker Discovery: Opportunities, Challenges and Future Perspectives
The pharmaceutical industry faces unsustainable program failure despite significant increases in investment. Dwindling discovery pipelines, rapidly expanding R&D budgets and increasing regulatory control, predict significant gaps in the future drug markets. The cumulative duration of discovery f...
Kaydedildi:
| Asıl Yazarlar: | , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
MDPI AG
2016-09-01
|
| Seri Bilgileri: | Proteomes |
| Konular: | |
| Online Erişim: | http://www.mdpi.com/2227-7382/4/3/28 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|